Cargando…

Efficacy of lower dose pirfenidone for idiopathic pulmonary fibrosis in real practice: a retrospective cohort study

BACKGROUND/AIMS: Pirfenidone slows the progression of idiopathic pulmonary fibrosis (IPF). We investigated its efficacy and safety in terms of dose and disease severity in real-world patients with IPF. METHODS: This multicenter retrospective cohort study investigated 338 patients treated with pirfen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hwang, Hyeontaek, Lee, Jung-Kyu, Choi, Sun Mi, Lee, Yeon Joo, Cho, Young-Jae, Yoon, Ho Il, Lee, Jae Ho, Lee, Choon-Taek, Kim, Young Whan, Park, Jong Sun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association of Internal Medicine 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925945/ https://www.ncbi.nlm.nih.gov/pubmed/34293852 http://dx.doi.org/10.3904/kjim.2020.559

Ejemplares similares

Impact of body weight change on clinical outcomes in patients with idiopathic pulmonary fibrosis receiving pirfenidone
por: Kim, Tae Hun, et al.
Publicado: (2022)

Clinical impact of depression and anxiety in patients with idiopathic pulmonary fibrosis
por: Lee, Ye Jin, et al.
Publicado: (2017)

Impact of mediastinal lymph node enlargement on the prognosis of idiopathic pulmonary fibrosis
por: Sin, Sooim, et al.
Publicado: (2018)

Prognosis of non-small-cell lung cancer in patients with idiopathic pulmonary fibrosis
por: Han, SongYi, et al.
Publicado: (2019)

Safety and Efficacy of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis: A Nationwide Post-Marketing Surveillance Study in Korean Patients
por: Chung, Man Pyo, et al.
Publicado: (2020)

Efficacy of Pirfenidone According to Dose in Patients with Idiopathic Pulmonary Fibrosis: A Prospective, Observational, Single-Center Cohort Study
por: Lee, Ho Young, et al.
Publicado: (2023)

Pirfenidone-Induced Lichenoid Drug Eruption in a Patient with Idiopathic Lung Fibrosis
por: Jeong, In Jae, et al.
Publicado: (2019)

Genetic variations in idiopathic pulmonary fibrosis and patient response to pirfenidone
por: Kubbara, Aahd, et al.
Publicado: (2023)

Pirfenidone-Induced Photosensitivity in a Patient with Idiopathic Pulmonary Fibrosis
por: Kim, Ho-Jin, et al.
Publicado: (2018)

Pirfenidone treatment of idiopathic pulmonary fibrosis
por: Gan, Ye, et al.
Publicado: (2011)

Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond
por: Aimo, Alberto, et al.
Publicado: (2022)

Efficacy of low dose pirfenidone in idiopathic pulmonary fibrosis: real world experience from a tertiary university hospital
por: Song, Myung Jin, et al.
Publicado: (2020)

Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
por: Tzouvelekis, Argyrios, et al.
Publicado: (2017)

Characterization of Microbiota in Bronchiectasis Patients with Different Disease Severities
por: Lee, Sang Hoon, et al.
Publicado: (2018)

The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis
por: Cottin, Vincent
Publicado: (2013)

Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
por: Takeda, Yoshito, et al.
Publicado: (2014)

Corrigendum: Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
por: Tzouvelekis, Argyrios, et al.
Publicado: (2018)

Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena
por: Vietri, Lucia, et al.
Publicado: (2020)

Prognosis of Small Cell Lung Cancer with Idiopathic Pulmonary Fibrosis: Assessment according to GAP Stage
por: Song, Myung Jin, et al.
Publicado: (2019)

Readmission to Medical Intensive Care Units: Risk Factors and Prediction
por: Jo, Yong Suk, et al.
Publicado: (2015)

Association of low fat mass with nontuberculous mycobacterial infection in patients with bronchiectasis
por: Lim, Sung Yoon, et al.
Publicado: (2021)

Effectiveness of pirfenidone in idiopathic pulmonary fibrosis according to the autoantibody status: a retrospective cohort study
por: Song, Myung Jin, et al.
Publicado: (2021)

Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation
por: Moon, Sung Woo, et al.
Publicado: (2019)

Significance of fractional exhaled nitric oxide in chronic eosinophilic pneumonia: a retrospective cohort study
por: Park, Ji Young, et al.
Publicado: (2014)

Prognosis of nontuberculous mycobacterial pulmonary disease according to the method of microbiologic diagnosis
por: Sin, Sooim, et al.
Publicado: (2021)

Who Dies after ICU Discharge? Retrospective Analysis of Prognostic Factors for In-Hospital Mortality of ICU Survivors
por: Lee, Jungsil, et al.
Publicado: (2017)

Longitudinal changes in lung hyperinflation in COPD
por: Park, Jimyung, et al.
Publicado: (2017)

Simultaneous reduction of flow and fraction of inspired oxygen (FiO(2)) versus reduction of flow first or FiO(2) first in patients ready to be weaned from high-flow nasal cannula oxygen therapy: study protocol for a randomized controlled trial (SLOWH trial)
por: Kim, Min Chul, et al.
Publicado: (2020)

Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis
por: Cottin, Vincent, et al.
Publicado: (2015)

Real world experience on the effectiveness and safety of pirfenidone in patients with idiopathic pulmonary fibrosis in Taiwan
por: Chang, Cheng-Yu, et al.
Publicado: (2023)

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis
por: van Manen, Mirjam J.G., et al.
Publicado: (2017)

Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis
por: Glassberg, Marilyn K., et al.
Publicado: (2019)

Successful High Flow Nasal Oxygen Therapy for Excessive Dynamic Airway Collapse: A Case Report
por: Park, Jisoo, et al.
Publicado: (2015)

Ultrasound Assessment Of Diaphragmatic Function During Acute Exacerbation Of Chronic Obstructive Pulmonary Disease: A Pilot Study
por: Lim, Sung Yoon, et al.
Publicado: (2019)

Comparing tuberculin skin test and interferon γ release assay (T-SPOT.TB) to diagnose latent tuberculosis infection in household contacts
por: Lee, Hyun Woo, et al.
Publicado: (2017)

Successful Rescue Therapy with Pumpless Extracorporeal Carbon Dioxide Removal in a Patient with Persistent Air Leakage due to Empyema
por: Cho, Jaeyoung, et al.
Publicado: (2017)

Analysis of avoidable cardiopulmonary resuscitation incidents with a part-time rapid response system in place
por: Cho, Jun Yeun, et al.
Publicado: (2021)

Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia
por: Lee, Hongyeul, et al.
Publicado: (2016)

Effects of low-dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): Results from a real-world study
por: Lee, Eung Gu, et al.
Publicado: (2021)

Comparison of viral infection in healthcare-associated pneumonia (HCAP) and community-acquired pneumonia (CAP)
por: Kim, Eun Sun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_s8c0unsk0ski40gp11pkc81bmi